Obinutuzumab Significantly Enhanced ADCC and Improves Overall Survival in CD20+ Primary Mediastinal B-Cell Lymphoma (PMBL) Xenograft NSG Mouse Model
Document Type
Abstract
Publication Date
9-2018
DOI
10.1111/bjh.15536
Journal Title
British Journal of Haematology
Department
Pediatrics
Second Department
Health Behavior and Community Health
Recommended Citation
Awasthi, A., Edani, D., Ayello, J., Klein, C., & Cairo, M. S. (2018). Obinutuzumab Significantly Enhanced ADCC and Improves Overall Survival in CD20+ Primary Mediastinal B-Cell Lymphoma (PMBL) Xenograft NSG Mouse Model. British Journal of Haematology, 182 (Suppl. 1), 65. https://doi.org/10.1111/bjh.15536
COinS